Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?

Executive Summary

After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office
Advertisement

Related Content

FTC Rulemaking Could Be Next (And Last?) Attempt To Curb "Pay-For-Delay"
FTC Rulemaking Could Be Next (And Last?) Attempt To Curb "Pay-For-Delay"
Reverse Settlements: FTC Commissioner, Circuit Judge, Former Solicitor General Debate When A Deal Is Acceptable
Reverse Settlements: FTC Commissioner, Circuit Judge, Former Solicitor General Debate When A Deal Is Acceptable
FTC, Energized By Androgel, Presses For Patent Settlement Ban
Abbott TriCor Settlement With Teva Adds Time For Product-Switching
Abbott TriCor Settlement With Teva Adds Time For Product-Switching
Brand/Generic Settlement Opponents May Have To Settle For Less
The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills
The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills

Topics

Advertisement
UsernamePublicRestriction

Register

PS051574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel